SCHEMBL18901296

SCHEMBL18901296

Cc1ccc2c(c1)oc(=O)c1cnccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 2/20 0.51
▸ CDC25A P30304 1/20 0.46
▸ CDC25C P30307 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ STAT1 P42224 1/20 0.43
▸ PDE2A O00408 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ JMJD6 Q6NYC1 1/20 0.41
▸ HSD17B3 P37058 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22373976 0.82 TDO2 (0.50) ROCK2KDM4ERAB9AMAOBALDH1A1
SCHEMBL862799 0.81 PDE2A (0.56) CDC25ACDC25CKDM4ERAB9AALDH1A1
SCHEMBL15240439 0.81 ROCK2 (0.48) ROCK2CDC25ACDC25CKDM4ERAB9A
SCHEMBL15973035 0.81 ROCK2 (0.48) ROCK2KDM4ERAB9AALDH1A1MAPT
SCHEMBL11209858 0.81 MAPT (0.70) ROCK2CDC25ACDC25CKDM4ERAB9A
SCHEMBL20308132 0.80 ACHE (0.45) ROCK2CDC25ACDC25CKDM4ERAB9A
SCHEMBL18901202 0.79 ROCK2 (0.46) ROCK2KDM4ERAB9AALDH1A1MAPT
SCHEMBL16377287 0.79 ROCK2 (0.46) ROCK2KDM4ERAB9AMAOBALDH1A1
SCHEMBL14389015 0.78 NPSR1 (0.64) CDC25ACDC25CKDM4ERAB9AMAOA
SCHEMBL13924644 0.78 CDC25A (0.54) CDC25ACDC25CKDM4ERAB9AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 — — EP disclosed
Send feedback